Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis

BACKGROUND: Recent works have suggested a possible link between interleukin (IL)-33 and B-cell biology. We aimed to study the possible association between serum IL-33 detection and response to rituximab (RTX) in rheumatoid arthritis (RA) patients in different cohorts with an accurate enzyme-linked i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Arthritis Res Ther
Päätekijät: Sellam, Jérémie, Rivière, Elodie, Courties, Alice, Rouzaire, Paul-Olivier, Tolusso, Barbara, Vital, Edward M., Emery, Paul, Ferraciolli, Gianfranco, Soubrier, Martin, Ly, Bineta, Hendel Chavez, Houria, Taoufik, Yassine, Dougados, Maxime, Mariette, Xavier
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5154136/
https://ncbi.nlm.nih.gov/pubmed/27964756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-1190-z
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia